Pakistan latest patents query
The latest invention patents collect the data information of Pakistan invention patents from 2000 to 2024, typesetting according to the date of patent publication, including patent number, application date, invention Bibliographic data, abstracts, and specification data of people are convenient for scientific researchers to quickly browse and search for patents.
A direct drive electric generator for vertical axis wind turbines.
UndeterminedPK201100567A0Vertical axis wind turbineElectric generator
Owner:DR SUHAIL ZAKI FAROOQUI
Suspension and cake composition containing carbostyryl derivative and silicone oil and / or silicone oil derivative.
UndeterminedPK201100609A0Polymer sciencePerylene derivatives
Owner:OTSUKA PHARM CO LTD
Development of a VIGS-DRIVEN Transformation System for Resistance against Phytophthora capsici via novel CaChiIII4 gene
PendingPK202600651A0BiotechnologyGene
Owner:MR MUHAMMAD ALI +3
Plant growth 8th March, 2012 regulator compounds
UndeterminedPK201200139A0
Owner:SYNGENTA PARTICIPATIONS AG
A system to administer an outcome based education
UndeterminedPK201100453A0Biomedical engineeringNursing
Owner:UNIVERSITI PUTRA MALAYSIA
A process for production of hydrochloric acid from sea salt
UndeterminedPK141367ADistilled waterSugar refining
Owner:MUHAMMAD KAMIL +1
An adhesion promoting compound for use in printing ink formulations
UndeterminedPK141212APrinting inkSynthetic resin
Owner:JOHNSON MATTHEY PLC
Compositions and methods for modulating the wnt signaling pathway
UndeterminedPK201100476A0Conduction pathwayBiochemistry
Owner:IRM +1
A novel process for the preparation of ibodutant (MEN15596).
UndeterminedPK141236AMethyl benzeneBiochemical engineering
Owner:MALESCI INST FARMACOBIOLOGICO
Training apparatus for martial arts or fitness training
UndeterminedPK201200151A0Software engineeringMechanical engineering
Owner:ANDREAS BUDEKER
An inventive apparatus using new process / method / system to generate 105,000 megawatts of electricity / power by using ICE as source of fuel and a new method / process to build & use a multi-purpose convertible (space-mirrors / lens)'s apparatus around LEO / HEO earth's orbits".
UndeterminedPK201200155A0Mechanical engineeringElectric power
Owner:NAEEM NAZIR MALIK
Primary amine diazeniumdiolate heterocyclic derivatives
UndeterminedPK201200124A0Perylene derivativesHeterocyclic derivatives
Owner:MERCK SHARP & DOHME CORP
Bicyclic triazole compound as protein kinase modulator.
UndeterminedPK141227ABiochemistryStereochemistry
Owner:SGX PHARMACEUTICALS INC
Use of dronedarone for the preparation of a medicament for the prevention of cardiovascular hospitalization or of mortality in patients with lone atrial fibrillation
UndeterminedPK201100542A0DronedaronePharmacy medicine
Owner:SANOFI SA(FR)
Electronic bearer bond online transaction system
UndeterminedPK201100558A0
Owner:AHSAN ILAHI RAJA SON OF ABDUL REHMAN SHEIKH
Subtituted 1,4dihydro-1,8-naphthyridine-3-carboxamidde compound
UndeterminedPK141372APharmaceutical drugCombinatorial chemistry
Owner:SANOFI AVENTIS SA
Imidazopyridine indolizine derivatives, process for the preparation thereof and therapeutic use thereof
UndeterminedPK201100505A0ImidazopyridinePyridyne
Owner:SANOFI SA(FR)
Synthetic Intermediates for the Preparation of Kinase Modulators
UndeterminedPK201100667A0Enzyme modulatorKinase
Owner:PLEXXIKON INC
Production method of intermediate compound for synthesizing medicament.
ActivePK201100613A0Pharmaceutical drugCombinatorial chemistry
Owner:LG CHEM LTD
Process for the Preparation of Enolate Salts of 4-Fluoro-2-hydroxymethylene-3-oxo-butyrates
UndeterminedPK201100526A0ButyrateMethylene radical
Owner:LONZA AG
New dihydrobenzoxathiazepine compounds, a process for their preparation and pharmaceutical compositions containing them.
UndeterminedPK201100619A0Pharmacy medicinePharmaceutical drug
Owner:LES LAB SERVIER SA
Dual variable domain immunoglobulins and uses thereof
UndeterminedPK201100521A0Intravenous gammaglobulinVariable domain
Owner:ABBOTT LAB INC
Germicidal composition containing Zinc thiazole
ActivePK201100668A0
Owner:ZHEJIANG XINNONG CHEM CO LTD
Dividable galenical form allowing modified release of the active ingredient.
UndeterminedPK141234APharmacy medicinePharmaceutical drug
Owner:LES LAB SERVIER SA
Process fo rth epreparation of enantiomeric forms of 2,3-iaminopropionic acid derivatives.
UndeterminedPK201100591A0Propanoic acidAcid derivative
Owner:SANOFI SA(FR)
Novel quinoline esters useful for treating skin disorders
UndeterminedPK201100517A0QuinolineBiochemistry
Owner:WYETH LLC
Oxadiazole inhibitors of leukotriene production.
UndeterminedPK201100599A0
Owner:BOEHRINGER INGELHEIM INT GMBH
Elisa based in vitro infectivity assay for serum derived HCV genotype 3a of Pakistani isolates
UndeterminedPK201100474A0HCV GenotypingInfectivity
Owner:DR ISHTIAQ QADRI +2
A process for selective removal of a product from a gaseous system
ActivePK201100475A0Process engineeringIndustrial engineering
Owner:CASALE SA
Pharmaceutically acceptable salt of a substituted benzofuranyl-ethyl-piperazinyl compound.
UndeterminedPK201100629A0Ethyl groupPharmaceutical medicine
Owner:MERCK SHARP & DOHME CORP
Pharmaceutical formulation comprising a phosphodiesterase inhibitor.
ActivePK201100565A0Phosphodiesterase inhibitorDepressant
Owner:CHIESI FARMACEUTICI SPA
A pharmaceutically acceptable salt of sulfonyl compound which selectively modulate the cb2 receptor.
UndeterminedPK201100616A0ReceptorAcyl group
Owner:BOEHRINGER INGELHEIM INT GMBH
Protein fusion constructs possessing thrombolytic and anticoagulant properties.
UndeterminedPK201100588A0BiochemistryBiomedical engineering
Owner:COUNCIL OF SCI & IND RES
Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament
UndeterminedPK201100500A0Pharmacy medicinePharmaceutical drug
Owner:SANOFI SA(FR)
(2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments
UndeterminedPK201100501A0Propanoic acidAcid derivative
Owner:SANOFI SA(FR)
Compositions comprising a fatty acid oil mixture, a surfactant, and a statin
UndeterminedPK201100670A0MedicineActive agent
Owner:PRONOVA BIOPHARMA NORGE
Clay pitcher arsenic removal filter
UndeterminedPK141370ARural areaArsenic pollution
Owner:DR MUHAMMAD ASLAM TAHIR (NWQL) +1
Fly ash brick masonry building system for sustainable and seismic- resistant construction
PendingPK202600640A0Architectural engineeringStructural engineering
Owner:PROF DR KHAN SHAHZADA +3
Use of anthranilamide derivatives for controlling insects and spider mites by drenching, soil mixing, furrow treatment, drip application, soil, stem or flower injection, in hydroponic system, by planting hole treatment or dip application, floating or seedbox application or by treating seed, and also for enhancing the stress tolerance of plants to abiotic stress
ActivePK201100537A0BiotechnologyPerylene derivatives
Owner:BAYER CROPSCIENCE AG
Pharmaceutically acceptable salt of (heterocycle-tetrahydropyridine) (pip erazinyl)-1-alkanone and (heterocycle -dihydropyrrolidine) (piperazinyl)-1-alkanone derivative
UndeterminedPK201100585A0EngineeringPharmaceutical medicine
Owner:SANOFI SA(FR)
Aeration apparatus, seawater flue gas desulphurization apparatus including the same, and operation method of aeration apparatus
UndeterminedPK201100481A0Flue gasEnvironmental engineering
Owner:MITSUBISHI HEAVY IND LTD
A process for the development of herbal brown hair dye
UndeterminedPK201200123A0Hair Coloring AgentsTraditional medicine
Owner:LUBNA LIAQUAT +4
Integrated process for producing compositions containing magnesium.
UndeterminedPK201100574A0Physical chemistryMagnesium
Owner:NOVACEM LTD
Herbicidal bis-nitrogen-containing oxo and sulfono heterocycles
UndeterminedPK201200145A0Combinatorial chemistryOrganic chemistry
Owner:EI DU PONT DE NEMOURS & CO
C4-monomethyl triterpenoid derivatives and methods of use tereof
UndeterminedPK201200154A0TriterpenoidBiochemistry
Owner:1 REATA PHARMA INC 2 TRUSTEES OF DARTMOUTH COLLEGE
Substituted quinazolinedione compound for the treatment of cardiovascular diseases.
UndeterminedPK141235ADiketonePharmacy medicine
RTS,S formulation stabilised by an agent comprising a thiol.
UndeterminedPK141223AMedicineBiochemistry
Owner:GLAXOSMITHKLINE BIOLOGICALS SA
An adjuvant composition comprising QS21, 3D-MPL and an immunostimulatory oligonucleotide.
UndeterminedPK141233APurineQS21
Owner:GLAXOSMITHKLINE BIOLOGICALS SA
A baked clay pitcher (bcp) irrigation system for multiple crop types.
UndeterminedPK201100624A0Soil scienceClay soil
Owner:AIR CMDR (R) AYAZ UL HAQ QUDDUSI
Process for preparing graft polymers without initiator and without solvent and bitumen / polymer compositions comprising said graft polymers
UndeterminedPK201100523A0Polymer sciencePolymer chemistry
Owner:TOTAL RAFFINAGE MARKETING +1
Pharmaceutically acceptable salt of 4phenoxypyrazole compound
UndeterminedPK141228AAcquired immunodeficiencyReverse transcriptase
Owner:PFIZER INC
Bioassay for the measurement of CEPO concentration and activity
UndeterminedPK201100541A0Biologic AssaysBiochemistry
Owner:H LUNDBECK AS
A process of preparation in vivo and in vitro methods for mass production of entomopathogenic nematodes as a biological control agent, alternative to chemical control
UndeterminedPK201100459A0Chemical controlMicrobiology
Owner:SAHINA FAYYAZ M H SOOMRO +1
Ready to use therapeutic food and method for manufacturing the same
UndeterminedPK201200137A0Therapeutic foodMechanical engineering
Owner:M S HEALTH EDUCATION & LITERACY PROGRAMME
The formulation of an ointment for multiple skin diseases
UndeterminedPK141369AAntifungalDisease
Owner:MRS ZAHRA YAQEEN +3
Sustained-release therapeutic agent for hypertension and renal dysfunction
UndeterminedPK201100470A0Renal functionPharmacology
Owner:TEIJIN PHARMA CO LTD
Derivatives of oxadiazole and pyridazine, their preparation and their application in therapeutics
UndeterminedPK201100545A0PyridazineCombinatorial chemistry
Owner:SANOFI SA(FR)
Mixture of fibre-reactive dyes and their use in a method for trichromatic dyeing or printing.
UndeterminedPK201100617A0FiberPolymer science
Owner:HUNTSMAN ADVANCED MATERIALS (SWITZERLAND) GMBH
2-Propane, 1-Hydroxy-3-(4-Hydroxy-3-Methoxyphenyl) loaded zinc nanoconstruct based Aerosol as Therapeutic agent for the treatment of High-Altitude Pulmonary Edema
PendingPK202600632A0Pulmonary edemaPhenyl group
Owner:IQRA SHARIF +4
Method and device for resisting wear from particle containing water on an impeller.
UndeterminedPK141239AImpellerWater turbine
Owner:DYNAVEC
Method of the System for Securely Processing a Transaction
UndeterminedPK201100457A0Computer hardwareFinancial transaction
Owner:BASF SE
Alkaloid aminoester derivatives and medicinal composition thereof
UndeterminedPK201100449A0Pharmaceutical drugAlkaloid
Owner:CHIESI FARMACEUTICI SPA
A synthetic immunogen useful for generating long lasting immunity and protection against pathogens
UndeterminedPK201100666A0Synthetic ImmunogensImmunity
Owner:COUNCIL OF SCI & IND RES +1
Bisaryl (thio)morpholine derivatives as s1p modulators
UndeterminedPK201100511A0ArylMorpholine
Owner:ABBOTT HEALHCARE PROD BV
Disinfectant and antiseptic formulation having reduced iodine content
UndeterminedPK201100529A0Organic chemistryMedicinal chemistry
Owner:EGIS GYOGYSZERGYAR NYILVANOSAN MUKODO RESZVENY TARSASAG
Macrocyclic hepatitis c serine protease inhibitors
ActivePK201200125A0Serine Protease InhibitorsGenetics
Owner:ABBVIE IRELAND UNLIMITED CO
Pharmaceutical compositions for treatment of respiratory and inflammatory diseases
UndeterminedPK201100554A0DiseasePharmaceutical drug
Owner:BOEHRINGER INGELHEIM INT GMBH
Balancing weight for a combing device of a combing machine
PendingPK202600636A0Software engineeringMechanical engineering
Owner:GRAF CIE AG
Novel microbiocidal dioxime ether derivatives
UndeterminedPK201100491A0
Owner:SYNGENTA PARTICIPATIONS AG
Precast concrete sandwich wall panel with recycled textile waste core for building construction
PendingPK202600639A0Architectural engineeringPrecast concrete
Owner:PROF DR KHAN SHAHZADA +3
A pharmaceutically acceptable salt of biphenyl-2-yl-carbamic acid 1-[9-(3-chloro-4-hydroxybenzoylamino)-nonyl]piperidin-4-yl ester and preparation thereof
UndeterminedPK201100539A0Pharmaceutical medicinePharmacology
Owner:PFIZER LTD
A physiologically acceptable salt of 2amino-benzimidazole-5-carboxamides as anti-inflammatory agents.
UndeterminedPK201100628A0Medicinal chemistryBenzimidazole
Owner:BOEHRINGER INGELHEIM INT GMBH
Method and composition for producing clarified sugar.
UndeterminedPK201100600A0BiotechnologyEngineering
Owner:JOSE RAIMUNDO FILHO
Prodrugs comprising an exendin linker conjugate
UndeterminedPK201100673A0
Owner:SANOFI AVENTIS DEUT GMBH
Methods and formulations of treating thrombosis with betrixaban and a pglycoprotein inhibitor.
UndeterminedPK201100634A0BetrixabanThrombus
Owner:PORTOLA PHARMA INC +1
A synergistic insecticidal composition comprising Citrullus colocynthis extract and green synthesized nanoparticles thereof for the management of sucking pests
PendingPK202600630A0Citrullus colocynthisNanoparticle
Owner:PROF DR SHAHID MANSOOR +6
Herbicidal bis-nitrogen-containing oxo heterocycles
UndeterminedPK201200129A0Combinatorial chemistryOrganic chemistry
Owner:EI DU PONT DE NEMOURS & CO
6-cycloamino-3-(pyridin-4-yl) imidazo [1,2-b]-pyridazine compound.
UndeterminedPK141222AArylPyridazine
Owner:SANOFI AVENTIS SA
Security improvements for flexible substrates
UndeterminedPK201100464A0
Owner:OMARCO NETWORK SOLUTIONS
Dual variable region antibody-like binding proteins having cross-over binding region orientation
UndeterminedPK201200152A0Antiendomysial antibodiesCell biology
Owner:SANOFI SA(FR)
Tetrasubstituted cyclohexyl compounds as kinase inhibitors
UndeterminedPK201200134A0DepressantOrganic chemistry
Owner:NOVARTIS AG
Pharmaceutically acceptable salt of substituted tetrahydropyran spiro pyrrolodinone and piperidinone
UndeterminedPK201100660A0PyrrolidinonesPharmaceutical medicine
Owner:SANOFI SA(FR)
Stabilizer for x-ray device
UndeterminedPK201100672A0
Owner:SOC ESPANOLA DE ELECTROMEDICINA & CALIDAD SA
Stabilized formulations containing anti-ngf antibodies
UndeterminedPK201100527A0Antiendomysial antibodiesBiochemistry
Owner:REGENERON PHARMACEUTICALS INC
Pharmaceutical depot for 5-fluoro-2-[[(1s)-1-(5-fluoro-2-pyridyl)ethyl]amino]-6-[(5-isopropoxy-1h-pyrazol-3-yl)amino]pyridine-3-carbonitrile
UndeterminedPK201100543A0Pharmaceutical drugCombinatorial chemistry
Owner:ASTRAZENECA AB
Iron (III) caseinsuccinylate and method for the preparation thereof
ActivePK201100461A0EngineeringOrganic chemistry
Owner:ITALFARMACO SPA
Process for the preparation of pan-CCDK inhibitors of the formula (I), and intermediates of the preparation
UndeterminedPK201100675A0Organic chemistryMedicinal chemistry
Owner:BAYER PHARMA AG
Phenylamidines having a high fungicidal activity and use thereof.
UndeterminedPK201100608A0Phenyl groupOrganic chemistry
Owner:ISAGRO RICERCA SRL
A vaccine composition comprising a saponin and an immunostimulatory oligonucleotide and a tumor associated antigen.
UndeterminedPK141229ASaporinOncology
Owner:GLAXOSMITHKLINE BIOLOGICALS SA
Pharmaceutical compositions comprising 4-amino-5-fluoro-3-[6-(4-methylpiperazin-1-yl)-1h-benzimidazol-2-yl]-1h-quinolin-2-one lactate monohydrate
UndeterminedPK201100480A0QuinolizinePharmaceutical drug
Owner:NOVARTIS AG
Pharmaceutically acceptable salt of a hexahydrooxazinopterine compound
UndeterminedPK141255APharmaceutical drugPterin
Owner:TAKEDA PHARMA CO LTD
Heterocyclic compounds, their preparation and their therapeutic application
UndeterminedPK201100454A0Medicinal chemistryPharmacology
Owner:FOVEA PHARMA
System and method for generating a strong multi factor personalized server key from a simple user password
UndeterminedPK201100562A0PersonalizationPassword
Owner:NIRMAL JUTHANI
Pharmaceutically acceptable salt of a substituted quinazolinedione compounds for the treatment of cardiovascular diseases.
UndeterminedPK201100590A0DiketonePharmaceutical medicine
Owner:SANOFI SA(FR)
Peptide or peptide complex binding to alpha2 integrin and methods and uses involving the same.
UndeterminedPK201100636A0BiochemistryIntegrin
Owner:SANOFI SA(FR)
Anticancer derivatives, preparation thereof and therapeutic use thereof
UndeterminedPK201100552A0Treatment useOrganic chemistry
Owner:SANOFI SA(FR)
Tuberculosis Drug Based on 4-Thioureido-Iminomethylpyridinium Perchlorate
UndeterminedPK201100533A0PyridiniumThiourea
Owner:JOINT CO PHARMASYNTEZ
Novel microbiocidal dioxime ether derivatives
UndeterminedPK201100556A0
Owner:SYNGENTA PARTICIPATIONS AG
Panthenyl docosahexaeneoate and its use for treating and preventing cardiovascular diseases.
UndeterminedPK201100575A0PharmacologyCardiovascular disorder prevention
Owner:PIERRE FABRE MEDICAMENT SAS
Construction and Purification of HCV NS3 recombinant Single Chain serine Protease with NS4a peptide of Genotype 3a from Pakistani Population.
UndeterminedPK201100582A0GenotypePakistani population
Owner:DR ISHTIAQ QADRI +1
Dual variable bomain immunoglobulins and uses thereof.
UndeterminedPK201100571A0Variable domainMechanical engineering
Owner:ABBOTT LAB INC